High-Dose Therapy and Autologous Blood Stem-Cell Transplantation Compared With Conventional Treatment in Myeloma Patients Aged 55 to 65 Years: Long-Term Results of a Randomized Control Trial From the Group Myelome-Autogreffe - Fermand, Jean-Paul; Katsahian, Sandrine; Divine, Marine; Leblond, Veronique; Dreyfus, Francois; Macro, Margaret; Arnulf, Bertrand; Royer, Bruno; Mariette, Xavier; Pertuiset, Edouard; Belanger, Coralie; Janvier, Maud; et al. (Journal of clinical oncology, 2005)
Keywords: Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols - therapeutic use; Biological and medical sciences; Busulfan - administration & dosage; Cyclophosphamide - administration & dosage; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Immunodeficiencies. Immunoglobulinopathies; Immunoglobulinopathies; Immunopathology; Male; Medical sciences; Melphalan - administration & dosage; Middle Aged; Multiple Myeloma - drug therapy; Peripheral Blood Stem Cell Transplantation; Prednisone - administration & dosage; Transplantation, Autologous; Treatment Outcome; Tumors; Vincristine - administration & dosage; Human; Immunopathology; Stem cell; Hematopoietic cell; Malignant hemopathy; Myeloma; Long term; Blood; Autograft; Cancerology; Treatment; Immunoglobulinopathy; Lymphoproliferative syndrome; Graft; Clinical trial; High dose